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    Development of a stool antigen immunoassay to detect Helicobacter pylori infection requires monoclonal 
antibody against the specific antigen. Alkylhydroperoxide reductase (AhpC) of Helicobacter pylori has been 
described as a specific and unique enzyme for H. pylori and therefore, both H. pylori AhpC and Anti-AhpC 
could be useful in the development of serologic and stool antigen tests, for detecting  and monitoring H. 
pylori infection. The aims of this study were to prepare a monoclonal antibody against AhpC. Accordingly, 
The isolation and purification of  AhpC from H. pylori were attempted by various techniques including 
ammonium sulfate precipitation, dialysis, preparative sodium dodecyl sulfate polyacrylamide gel 
electrophoresis and electroelution. Furthermore mice were immunized intraperitoneally with homogenized 
gel containing the AhpC band of protein  extract of H. pylori in sodium dodecyl sulfate- polyacrylamide gel 
electrophoresis. The monoclonal antibody was produced using the hybridoma technique. 
One-dimensional preparative gel electrophoresis allows a single and short purification step, the high-
resolution capacity of this technique leads to a high level of purity of the enzyme and consequently to a very 
high specificity of the antibody. The high specificity of antibody was identified by immune blotting in which 
the antibody reacted with the purified AhpC and whole cell protein extract from H. pylori in addition to the 
intact cells of H. pylori. This approach is simple, time and cost-saving for preparation of monoclonal 
antibody against AhpC of H. pylori. 
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INTRODUCTION 
    Helicobacter pylori, a spiral Gram-negative 
microaerophilic bacterium, contains an 
alkylhydroperoxide reductase (AhpC) homologue 
that is closer to eukaryotic peroxiredoxin than 
other bacterial AhpC [1, 2]. H. pylori AhpC is a 
major component of the AhpC-thioredoxin- 
thioredoxin reductase dependent peroxiredoxin 
system that catalyzes the reduction of 
hydroperoxides including H2O2 and organic 
hydroperoxides, and the reduction of peroxinitrite 
[1-3]. In addition to AhpC, there are two other 
members of peroxiredoxin family in H. pylori 
which are called thiol-specific peroxidase (Tpx), 
and bacterioferritin comigratory protein (Bcp) that 
have similar activities as the AhpC [4-6]. 
The AhpC has previously been reported as a 
species-specific protein that is antigenically 
conserved [7]. Although not identified as a 
peroxidase at that time, the alkylhydroperoxide 
reductase was characterized as a homodimer of 26 
kDa polypeptide chains with inter-chain disulfide 
linkages and the protein was also suggested to be 
useful as a diagnostic antigen in enzyme 
immunoassay (EIA) tests for detection of H. 
pylori infection [7]. 
H. pylori express abundant levels of AhpC. Based 
on densitometric measurement of the protein 
bands on the gel, it has shown that this protein 
constitutes more than 2% of the total protein in 
the wild- type cell [8], confirming the results of 
proteome analysis which  showed AhpC is the 
third most abundant protein in H. pylori [9]. 
Sequencing analysis revealed 20-30% homology 
between H. pylori AhpC and other bacterial AhpC, 
and around 43% homology with mammalian 
peroxiredoxin [10]. In addition, by 
immunoblotting on the stool of the infected 
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individuals, Pourakbari et al. showed that the 
AhpC antigen was present in many samples and 
suggested that this antigen is one of the major 
antigens of H. pylori which is released into the 
stool and can be considered as a diagnostic 
antigen to detect H. pylori infection [11]. In 
Mohammadian et al reports using Western blot 
and immunodot blot analyses they also showed 
that AhpC subunits are detectable in the fecal 
antigenic extract of infected patients [12, 13]. 
Furthermore, using comparative proteomic and 
immunoproteomic analysis of different H. pylori 
strains revealed AhpC as a protein with potential 
diagnostic and therapeutic values [14]. 
Alkylhydroperoxide reductase is one of the most 
conserved and unique H. pylori antigens. Thus, 
antibodies against this protein are potentially 
useful tools for detecting and monitoring H. pylori 
infection in stool. It may also serve as a potential 
target for antimicrobial agents or vaccine 
development [15]. In addition, The AhpC has 
been identified as biomarker related to H. pylori 
associated gastro duodenal disease [16]. In the 
present study we tried to produce a monoclonal 
antibody against AhpC, in order to detect H. 
pylori infection by enzyme immunoassay. 
 
MATERIALS AND METHODS 
Bacterial strains 
     Five clinical strains of H. pylori were isolated 
from biopsy specimens of five patients with 
gastritis. Biopsies were delivered to the 
microbiology laboratory in transport medium. 
Samples were cultured immediately on selective 
Brucella agar containing 5% sheep blood, 
vancomycin (5 mg/L), trimethoprim (5 mg/L) and 
polymyxin B (2500 u/L). After 2-3 days of 
microaerobic incubation at 37 
o
C, single colonies 
were cultured on Brucella blood agar. Bacterial 
strains were identified as H. pylori according to 
microscopic observation of Gram-negative spiral 
bacteria and positive catalase, oxidase and urease 
reactions.  
To obtain about 6.5 g of a mixed bacterial pellet, 
400 plated cultures of five H. pylori strains were 
harvested and suspended in phosphate-buffered 
saline (PBS) and centrifuged at 5000×g for 20 





Protein extraction from bacteria 
 In order to extract proteins from H. pylori, frozen 
cell pellets were thawed, suspended in PBS  (pH 
7.2) containing 1.0 mmol/L phenylmethylsulfonyl 
fluoride (Acros Organics, Fair Lawn, NJ, USA), 4 
mmol/L EDTA and 0.6% (w/v) octyl-β-D 
glucopyranoside (Sigma-Aldrich, St Louis, MO, 
USA), and incubated for 60 minutes at an ambient 
temperature with gentle agitation. Samples were 
then centrifuged at 6000×g for 15 minutes and the 
supernatants were collected. The procedure was 
repeated once more on the bacterial pellet. Pooled 
supernatants were cleared by centrifugation at 
35,000×g for 20 minutes and 50% ammonium 
sulfate was added to the supernatant. Following 
overnight incubation at 4 
o
C, the sample was spun 
at 35,000×g for 30 minutes and the pellet was 
suspended in 5 mL of 0.05 mol/L Tris-HCl 
containing 0.145 mol/L NaCl (Tris-saline [pH 
7.5]). The sample was dialyzed against the same 
buffer and protein assay was performed as 
described previously [17]. 
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis  
One-dimensional preparative and analytical 
sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAG)  were performed in a 
vertical slab gel unit using 12.5% separating gels 
and 5.0% stacking gels [18]. The  protein extract 
(1.5 mL) was separated by preparative SDS-
PAGE (180 ×160 × 2.5 mm) using Tris-HCl 
buffer (pH 8.8) and stained with Coomassie 
Brilliant Blue solution [10% acetic acid, 40% 
methanol and 0.1% Coomassie Brilliant Blue 
(CBB)-R250]. Analytical electrophoresis was also 
performed as described above. 
Removal of CBB-R250 and electrophoretic 
elution of proteins from gel  
In order to extract the protein from polyacryl 
amide gel, a method of electrophoretic elution 
was applied using dialysis membrane for protein 
retention [19-23]. Protein band with 26 kDa size 
was excised and cut into small fragments. 
Removing of CBB-R250 from the gel fragments 
was performed according to the Ball method [23]. 
Briefly, destaining solution containing 50% 
isopropanol and 3.0% SDS was added to gel 
pieces in 12×75 mm glass test tubes, and the tubes 
were capped with parafilm. Tubes were placed in 
a 37 
o
C water bath set for overnight without 
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agitation. After cooling to room temperature, the 
liquid was removed and the gel fragments 
containing the appropriate protein were used for 
mouse immunization and electrophoretic elution. 
For electophoretic elution, gel fragments were 
equilibrated twice in 0.125 mol/L Tris-HCl buffer 
(pH 6.8) and 2.0% solution of 2-mercaptoethanol 
for 15 minutes. A final equilibration of the gel 
fragments in 0.125 mol/L Tris-HCl buffer (pH 6.8) 
containing 1.0% (w/v) SDS was performed. The 
equilibrated gel fragments were then placed in a 
dialysis tube with a minimum amount of Tris-
glycine buffer containing SDS (25 mmol/L Tris, 
192 mmol/L glycine, and 0.1% SDS). The dialysis 
tubes were treated, and electroelution was carried 
out as described previously [20]. Briefly, 
electroelution was performed at 50 V for 12 hours 
at 4 
o
C in Tris-glycine buffer containing 0.1% 
SDS (pH 8.3). At the end of electrophoretic 
elution, the polarity of the electrodes was changed 
for 60 seconds in order to avoid the absorption of 
protein on the dialysis tubes. 
Production of monoclonal antibody 
BABL/c mice were immunized with homogenized 
gel fragments containing approximately 20 µg of 
the protein without Freund’s adjuvant by 
intraperitoneal injection and boosted at 3 weekly 
intervals with a further 20 µg of 26 kDa protein, a 
total of four injection. Monoclonal antibody 
production was carried out essentially by the 
method Köhler and Milstein (24). Exception that 
cell fusion was achieved using polyethylene 
glycol. Monoclonal antibody fusion supernatants 
were tested against a crude antigen preparation of 
H. pylori in ELISA and immunoblotting. A 
hybridoma secreting the appropriate monoclonal 
was recloned a second time to preserve stability. 
Indirect enzyme-linked immunosorbent assay 
Titration of the antibodies in the supernatant of 
clones were performed by indirect enzyme-linked 
immunosorbent assay (ELISA), using the purified 
26 kDa protein as the antigen. 
ELISA wells were coated with 100 µL of 26 kDa 
protein (0.2-1 µg/mL) in PBS (pH 7.5) and 
incubated at 4
o
C for overnight. After incubation, 
plates were washed three times with washing 
solution [PBS containing 0.05% Tween 20 (PBS-
T)] and nonspecific sites were blocked with 2% 
bovine serum albumin (BSA) in washing solution 
for 2 hours at 37 
o
C. After blocking, plates were 
washed as done previously and incubated with 
hybridoma suprernatant for 2 hours at 37 
o
C. The 
plates were washed and incubated with goat anti-
mouse IgG-peroxidase conjugate for 2 hours at 
37
o
C; then unbound conjugated antibodies were 
removed by washing and color development was 
performed using 3, 3', 5, 5' tetramethyl benzidine 
(TMB) as substrate. Finally the reaction was 
stopped with 50 µL per well of 1 mol/L HCl, and 
the absorbance at 450 nm was recorded using 
microplate reader (Anthos Labtec, Salzburg, 
Austria). 
Western immunoblotting 
Immunoblotting was performed as described 
previously [25]. Briefly, H. pylori extracts were 
electrophoresed on SDS-PAGE gel and separated 
proteins were blotted on nitrocellulose paper 
(NCP). After blotting, NCP was blocked with 2% 
solution of BSA in PBS-T for 1 hour at room 
temperature. The NCP was then incubated with 
the appropriate dilution (1:20) of antibody in 
PBS-T for 2 hours. The NCP was then washed 
three times with PBS-T and goat antirabbits IgG 
conjugated to horseradish peroxidase (HRP) 
(1:500) was added and incubated for 1hour at 
room temperature. After incubation, the NCP was 
washed three times with PBS-T, and protein 
bands were visualized by adding a mixture of  
hydrogen peroxide as the HRP substrate and 3,3′-
diamino tetra hydrochloride (DAB) (BHD limited, 
Poole UK) as the chromogen reagent. 
 Immunodot blotting 
Dot blotting was performed by transferring 10 µg 
of protein sample to NCP. After the NCP was 
dried at 37 
o
C for 1 hour, it was blocked with a 
2% solution of BSA in PBS-T. After blocking, the 
appropriate dilution of antibody was added to 
NCP and incubated at room temperature for 1 
hour. Finally, NCP was washed and developed by 
the procedure described for Western blotting. 
 
RESULTS 
     In the first step, cultured bacterial clinical 
strains were identified as H. pylori according to 
microscopic observation of Gram-negative spiral 
bacteria and positive catalase, oxidase, and urease 
reaction (Figure 1). Figure 2 shows preparative 
SDS-PAGE of whole cell protein extract of H. 
pylori. The molecular weight standard was 
applied in the middle well between two wide 
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wells to determine the approximate size of protein 
bands. 
The crude extract from H. pylori showed a 
brownish color and contained approximately 30 
bands when analyzed in a CBB-R 250 stained 
SDS-PAGE gel as shown in Fig 3, lane A. Figure 
3, lane B shows that in an analytical SDS-PAGE, 
the electroeluted protein migrated as a single band 
indicating its purity to homogeneity.  
In order to characterization of antibody, 
immunoblotting was performed. Fig. 4 and 5 
show dot blot assay and Western blotting with 
antibody respectively. 





















Figure 2. Preparative sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) of H. pylori protein extract. 
The middle lane shows the molecular weight markers of 66, 
45, 36, 29, 24, 20, and 14.2 kDa, respectively. Arrows 














Figure 3. Analytical sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis of H. pylori extract 
and its purified alkylhydroperoxide reductase (AhpC). Lane 
M: molecular weight markers: Lane A: whole cell protein 




Figure 4. Dot blot assay with antibody. (A) cell extract from 
cultured Escherichia coli as negative control; (B) the purified 
26 kDa; (C) whole cell protein extract; (D) intact H. pylori 


















Figure 5. Western blot analysis using produced monoclonal 
antibody in mouse. Lane M: prestained protein markers, lane 
A: whole cell protein extract in non-reducing condition, lane 
B: whole cell protein extract in reducing condition, lane C: 
the purified 26 kDa protein (AhpC).           
 




     Stool-antigen detection kits for diagnosis of 
Helicobacter pylori infection have been widely 
used because of their full non-invasive nature. 
Because Helicobacter pylori strains show a 
distinctive genetic diversity, it is important to find 
a protein that is a common antigen of various 
strains and shows a strong immunogenicity for the 
development of a stool antigen detection kit.   
Alkylhydroperoxide reductase of H. pylori is the 
most extensively studied H. pylori peroxiredoxin 
system. AhpC of H. pylori has been suggested to 
be a potential target for the development of 
therapeutic agent against H. pylori [15]. 
Furthermore application of monoclonal antibodies 
against H. pylori- specific antigens such as AhpC 
may increase the specificity of EIA for detecting 
and monitoring H. pylori infection, and anti-AhpC 
antibodies are useful tools for proteomic studies 
of H. pylori.  
Alkylhydroperoxide reductase of H. pylori is 
typically purified using two or more 
chromatographic steps [7, 26-28]. These protocols 
often involve a precipitation step, followed by an 
ion-exchange and/or gel filtration chromatography. 
Another approach is based on molecular biology 
tools, involving cloning the gene in an appropriate 
expression vector to produce the recombinant 
enzyme [1, 2, 10, 11, 29 and 30]. 
Furthermore, the way to produce monoclonal 
antibody against a protein is inject the protein into 
laboratory animals. The antigen can be obtained 
from standard purification techniques described 
above. However, the procedures are work 
consuming and costly. 
In the present work, a different methodology was 
used to simplify the purification and antibody 
production against H. pylori proteins. This 
approach is based on preparative SDS-PAGE, 
electroelution and antibody production using the 
natural protein separated by gel electrophoresis. 
In the first step, cultured bacterial clinical strains 
were as were identified as H. pylori according to 
microscopic observation of Gram-negative spiral 
bacteria and positive catalase, oxidase, and urease 
reaction (Figure 1).  
The whole cell protein extraction was then carried 
out by various techniques including 
ultracentrifugation, ammonium sulfate 
precipitation, and dialysis techniques. For the 
preparative SDS-PAGE, protein extract was run at 
50 V for 12 hours. The molecular weight standard 
was applied in the middle well between two wide 
wells to determine the approximate size of protein 
bands. After electrophoresis the gel was stained 
with CBB-R250 and destained for revealing 
protein bands (Figure 2).  The 26 kDa protein 
band was then excised, cut into small species and 
destained completely according to the Ball 
method [23]. Gel pieces were subsequently 
homogenized for mice immunization and dialyzed 
in bags previously filled with 25 mmol/L Tris 
buffer containing 192 mmol/L glycine and 0.1% 
SDS, pH 8.3. The appropriate identified tubing 
was placed in a horizontal flat bed gel 
electrophoresis apparatus, filled with the same 
buffer mentioned above. Electroelution of the 
protein from gel fragments was performed at 50 V 
for 12 hours finally, the gel fragments were 
discarded and the protein concentration was 
determined to be 200 µg/mL with the enzymatic 
activity of 26210 U/mg protein. Figure 3 (lane B) 
shows that in an analytical SDS-PAGE, the 
electroeluted protein migrated as a single band 
indicating its purity to homogeneity.  
While the AhpC of H. pylori has been purified by 
several multi-step procedures [7, 26-28] the 
present report provides a simple method for 
purification of this protein. Moreover, several 
type of apparatus for electroelution are 
commercially available [31, 32], but we used only 
electrophoretic elution using dialysis membrane 
for protein retention with good results. 
Furthermore, the protein band separated on a 
preparative SDS-PAGE elicited good immune 
response in mice after immunization with 26 kDa 
protein in gel, as measured by ELISA against a 
whole cell protein extract, because 
polyacrylamide helps to retain the antigen in the 
injection site, and thus acts as an adjuvant [33].  
The specificity of the antibody was further 
identified by immunoblotting systems. As it is 
obvious in Figure 4 the antibody react with the 
same purified electroeluted antigen, whole cell 
protein extract of H. pylori and the washed intact 
bacterial cells in dot blot assay. The reaction with 
intact cells indicates that some part of AhpC is 
exposed on the bacterial cell surface, confirming 
the report by of Lindholm and coworkers, in 
which they showed that AhpC could be detected 
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on the surface of H. pylori [27]. It was also noted 
that our preparation of purified H. pylori thiol-
specific peroxidase did not react with the antibody 
(Figure 4, dot E) which is in agreement with the 
results of Wan et al. [34]. Western blotting 
analysis revealed that the antibody can bind 
specifically with the dimeric native and denatured 
forms of the AhpC (Figure 5). Taken together, our 
results suggest that the antibody can specifically 
detect H. pylori AhpC. 
In the present study, we used a simple method to 
purify AhpC and produce antibody against it. This 
technique avoids both the long term purification 
of the AhpC and the need to add Freundۥs 
adjuvant.  
CONCLUSION 
     The approach presented here has following 
advantages: it does not require special expensive 
apparatus and reagents and preparative-scale 
amounts of AhpC could be purified. It is not time 
consuming and monoclonal antibody was 
produced against natural AhpC in gel bands 
instead of using recombinant protein for 
production monoclonal antibody. 
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